- Study: China outpaces the US in cancer approvals, lags behind on first approvalsWhile China's National Medical Products Administration (NMPA) approved more oncology drugs compared to the US Food and Drug Administration (FDA) from 2020 to 2025, the US regulator approved more fi…raps · 8d ago↗ source
- MHRA touts uptick in approvals in 2025-2026 annual reportThe UK's Medicines and Healthcare products Regulatory Agency (MHRA) touted its achievements over the last year its 2025-2026 annual report to Parliament, which includes approving more new drugs tha…raps · 8d ago↗ source
- Latigo preps IPO to fund non-opioid pain drug rival to Vertex’s JournaxLatigo Biotherapeutics is preparing to go public in order to bankroll the development of its clinical-stage pipeline of non-opioid pain management drugs.